VanEck Biotech ETF
BBH
BBH
71 hedge funds and large institutions have $120M invested in VanEck Biotech ETF in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 30 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 30
68% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 25
Holders
71
Holding in Top 10
–
Calls
$6.29M
Puts
$3.83M
Top Buyers
| 1 | +$4.39M | |
| 2 | +$2.8M | |
| 3 | +$2.64M | |
| 4 |
SG Americas Securities
New York
|
+$2.23M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$974K |
Top Sellers
| 1 | -$8.85M | |
| 2 | -$2.18M | |
| 3 | -$1.68M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.43M |
| 5 |
GP
GLG Partners
London,
United Kingdom
|
-$1.38M |